P. Brousset et al., FREQUENT EXPRESSION OF THE CELL DEATH-INDUCING GENE BAX IN REED-STERNBERG CELLS OF HODGKINS-DISEASE, Blood, 87(6), 1996, pp. 2470-2475
The expression of a cell death-inducing gene, Bax, was investigated in
52 cases of Hodgkin's disease in parallel with Epstein-Barr virus sta
tus and was compared with the immunodetection of other apoptosis-regul
ating proteins, Mcl-1, Bcl-2, and Bcl-x. Bar immunostaining was found
in 92% of the cases, among them 28% with a strong signal in more than
75% of the Reed-Sternberg cells. Mcl-1 was positive in 80% of the case
s, whereas Bcl-2 and Bcl-x were found in 53% and 88% of the cases, res
pectively. Of 48 (89%) Bax-positive tumors, 43 were found to express a
poptosis-inhibiting proteins such as Mcl-1 or Bcl-2. With the exceptio
n of 1 case, all Bar-positive tumors also expressed either Bcl-2, Bcl-
x, Mcl-1, or combinations of these anti-apoptotic proteins. No correla
tion was found between Bar expression and the presence of apoptotic ce
lls as detected by morphology and the in situ 3' OH-DNA end-labeling t
echnique. Our findings show that the apoptosis-inducing gene Bar expre
ssion is frequently expressed in Hodgkin's disease, providing a potent
ial explanation for the good chemoresponses generally obtained for pat
ients with this neoplastic disorder. (C) 1996 by The American Society
of Hematology.